VISIONFLEX GROUP LIMITED — Interim / Quarterly Report 2026

Apr 28, 2026

visionflex group

ASX Announcement – 29 April 2026

Visionflex Group Limited (ASX:VFX)

Q3 FY26 Quarterly Activity Report

Highlights:

• Cash receipts of $0.8m, down 12% on the pcp, reflecting softer hardware sales and the timing of customer payments
• Operating cash outflow of $0.7m, a $0.6m improvement from a $1.3m outflow in the pcp, reflecting the full-period benefit of the February cost reset
• Unaudited revenue of $1.0m, up 24% on the pcp
• Annual Recurring Revenue of $1.99m at the end of Q3 FY26, up 20% on the pcp

Visionflex Group Limited (“VFX” or the “Company”), a leader in virtual healthcare technology, provides its Appendix 4C and quarterly market update for the 3 months ending 31 March 2026.

Visionflex CEO & Managing Director, Joshua Mundey commented: “Q3 FY26 was a mixed quarter, with quarterly revenue growing 24% on the prior corresponding period, while customer cash receipts declined 12% and underlying ARR was broadly flat on Q2 FY26.

While procurement timing on certain enterprise opportunities impacted quarterly cash receipts, we remain focused on advancing several larger commercial opportunities currently within the pipeline.

The February workforce restructuring is now fully embedded in the cost base and has materially reduced operating cash outflow. Management continues to operate the business with appropriate financial discipline and a clear focus on capital management.

Engagement remains active across residential aged care, ACCHOs, mining and resources, and broader enterprise health. We continue to progress strategic partnerships and integration pathways that we believe can support scale and broader adoption.

With an improved operating cost base, active commercial opportunities and the available Adcock Private Equity facility, the Company enters Q4FY26 focused on execution, customer retention and continued transition to a recurring revenue model”.

Financial Performance – Q3 FY26 and FY26 YTD

Customer cash receipts totalled $0.8 million, which was a decrease of 12% on the pcp. Year to date customer cash receipts totalled $2.8 million, an increase of 12% on the pcp.

Operating and administration payments for the quarter were $1.5 million, $0.4 million lower than Q3 FY25, reflecting the full-period benefit of the February workforce restructuring. Year to date operating and administration payments made were $5.3 million, which was an 18% decrease on the pcp.

The operating cash outflow for the quarter was $0.7 million, an improvement from the $1.3 million outflow in the pcp. Year to date the operating cash outflow was $2.0 million, which was a 43% improvement on the pcp.

Unaudited revenue was $1.0 million, up 24% on the pcp. Year to date unaudited revenue was $2.7 million, which was materially in line with the result in the pcp.

Approximately 55% of the Q3 FY26 revenue was recurring in nature.

Visionflex Group Limited ACN 138 897 533 Unit 1, 8 Prosperity Parade, Warriewood NSW 2102

---

visionflex group

ASX Announcement – 29 April 2026

Visionflex Group Limited (ASX:VFX)

ARR was $1.99 million at the end of March 2026, up 20% on the pcp. The ARR balance at the end of Q3 FY26 was up 2% on Q2 FY26 on a headline basis, and broadly flat on a like-for-like basis excluding non-recurring items.

As at 31 March 2026, the Company held $0.5 million of cash, with a further $0.85 million available under its existing debt facility with cornerstone investor, Adcock Private Equity.

Remuneration for Mr Mundey and Mr Kafrouni in their executive roles and Mr Adcock in his role as a Director has been disclosed as related party transactions in the Appendix 4C.

Operational Highlights

• Amplar Health (Medibank): Payment received for an additional 10 Visionflex solutions, bringing total paid deployments to 30, following the rollout across the first 19 residential aged care facilities.
• Indigenous Health Expansion (ACCHOs): Expansion of the Company’s ACCHO footprint with six new virtual care deployments secured during the period, including a first-of-its-kind remote mobile clinic implementation with Urapuntja Health in the Northern Territory.
• Product & Platform: Continued focus on core platform functionality, unattended access capability, user experience enhancements and integration readiness to support broader enterprise deployment opportunities.
• Strategic Engagement: The Company continues to advance engagement with service providers, government and channel partners regarding distribution and broader commercial partnership opportunities.

Outlook

The Company remains focused on cost discipline, the conversion of advanced pipeline opportunities, and the ongoing transition from hardware led to recurring subscription revenue. Subscription churn pressure is expected to remain elevated in the current macroeconomic environment, and customer retention is a key operational priority.

The Company continues to progress a number of large enterprise opportunities within its sales pipeline. Timing of conversion remains outside the Company’s control and subject to customer procurement processes. The Company is not in a position to provide guidance on Q4 FY26 operating cash flow at this time, and will update the market as and when material developments occur.

-- END --

This announcement was approved for release by the Board of Directors.

For more information:

Joshua Mundey
Managing Director and CEO, Visionflex Group
jmundey@visionflex.com

About Visionflex Group

At Visionflex, we believe that healthcare should be accessible, efficient, and connected. Our integrated hardware and software platform allows healthcare providers to deliver comprehensive, collaborative care in real time, no matter the location. From metropolitan health networks to community-based care, Visionflex is reshaping how healthcare is delivered by connecting healthcare teams with the tools and technology needed to provide effective, efficient, and high-quality care. For more information, visit vfx-group.com.

Visionflex Group Limited ACN 138 897 533 Unit 1, 8 Prosperity Parade, Warriewood NSW 2102